PlainRecalls
FDA Drug Low Class III Terminated

Azelastine HCl Nasal Solution, 0.1 %, 137 mcg/spray, 30 mL bottle (200 Metered Sprays), Rx only, Mfg by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, NDC 60505-0833-5.

Reported: September 5, 2012 Initiated: June 15, 2011 #D-1667-2012

Product Description

Azelastine HCl Nasal Solution, 0.1 %, 137 mcg/spray, 30 mL bottle (200 Metered Sprays), Rx only, Mfg by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, NDC 60505-0833-5.

Reason for Recall

CGMP Deviations: tubing used for filling may interact with the nasal formulation of this product.

Details

Recalling Firm
Apotex Corp.
Units Affected
963,407 bottles
Distribution
Nationwide and Puerto Rico
Location
Weston, FL

Frequently Asked Questions

What product was recalled?
Azelastine HCl Nasal Solution, 0.1 %, 137 mcg/spray, 30 mL bottle (200 Metered Sprays), Rx only, Mfg by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, NDC 60505-0833-5.. Recalled by Apotex Corp.. Units affected: 963,407 bottles.
Why was this product recalled?
CGMP Deviations: tubing used for filling may interact with the nasal formulation of this product.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 5, 2012. Severity: Low. Recall number: D-1667-2012.